Skip Navigation LinksHome > Current Issue > Clinical Trial Alert
Text sizing:
A
A
A
Nephrology Times:
doi: 10.1097/01.NEP.0000426015.46579.98
Clinical Trial Alert

Clinical Trial Alert

Free Access

The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

Back to Top | Article Outline

• Acute Kidney Injury •

NCT01735162

Study of the Prediction of Acute Kidney Injury in Children Using Risk Stratification and Biomarkers

Ages eligible for study: Not listed

Sponsors and collaborators: Cincinnati Children's Hospital Medical Center

Contact: Rajit Basu, MD

Phone: 513-636-4259

E-mail: rajit.basu@cchmc.org

Contact: Stuart Goldstein, MD

Phone: 513-636-2209

E-mail: stuart.goldstein@cchmc.org

Back to Top | Article Outline
NCT01721928

Norwegian Intensive Care Unit Dalteparin Effect Study

Ages eligible for study: 18 years and older

Sponsors and collaborators: Oslo University Hospital, University of Oslo

Contact: Sigrid Beitland, MD

Phone: +4722117387

E-mail: sigrid.beitland@medisin.uio.no

Contact: Kjetil Sunde

Phone: +4722119585

E-mail: kjetil.sunde@medisin.uio.no

Back to Top | Article Outline

• Cardiovascular Disease •

NCT01709994

Primary Cardiovascular Risk Prevention with Aspirin in Chronic Kidney Disease Patients

Ages eligible for study: 45 years to 79 years

Sponsors and collaborators: Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales

Contact: Jose Luño, MD, PhD

Phone: 0034915868319

E-mail: jluno.hgugm@salud.madrid.org

Back to Top | Article Outline
NCT01711723

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects with Severe Renal Impairment

Ages eligible for study: 18 years to 75 years

Sponsors and collaborators: GlaxoSmithKline

Contact: US GSK Clinical Trials Call Center

Phone: 877-379-3718

E-mail: gskclinicalsupporthd@gsk.com

Back to Top | Article Outline

• Chronic Kidney Disease •

NCT01701830

Serum Omentin-1 and Carotid Atherosclerosis in Nondiabetic Chronic Kidney Disease

Ages eligible for study: 18 years to 75 years

Sponsors and collaborators: Kocaeli Derince Education and Research Hospital

Contact: Rabia Terzi, MD

Phone: 90262 317 80 00, ext. 8110

E-mail: drrabia1@yahoo.com

Back to Top | Article Outline
NCT01717248

Safety Study of GCS-100 to Treat Chronic Kidney Disease

Ages eligible for study: 18 years to 75 years

Sponsors and collaborators: La Jolla Pharmaceutical Company

Contact: George Tidmarsh, MD, PhD

Phone: 650-208-3191

E-mail: gtidmarsh@ljpc.com

Back to Top | Article Outline

• Chronic Kidney Disease–Mineral and Bone Disorder •

NCT01704079

Safety and Efficacy of CTAP101 Capsules for Treatment of SHPT and Vitamin D Insufficiency

Ages eligible for study: 18 years to 85 years

Sponsors and collaborators: Cytochroma

Contact: Rose Green, RPh

Phone: 847-236-7707, ext. 204

E-mail: rose.green@cytochroma.com

Contact: Joel Melnick, MD

Phone: 847-236-7707, ext. 243

E-mail: joel.melnick@cytochroma.com

Back to Top | Article Outline

• Diabetes •

NCT01712061

A Phase 2 Multicenter Study to Evaluate the Efficacy and Safety of a Chemokine CCR2/5 Receptor Antagonist in Adults with Type 2 Diabetes and Overt Nephropathy

Ages eligible for study: 18 years and older

Sponsors and collaborators: Pfizer

Contact: Pfizer CT.gov Call Center

Phone: 800-718-1021

Back to Top | Article Outline

• End-Stage Renal Disease •

NCT01704339

Qutenza for Critical Ischemia in End-Stage Renal Failure

Ages eligible for study: 18 years and older

Sponsors and collaborators: Emma Aitken, NHS Greater Glasgow and Clyde

Contact: Emma L. Aitken, MBChB

Phone: 01412111750

E-mail: EmmaAitken@nhs.net

Contact: David B. Kingsmore, MBChB

Phone: 01412111750

E-mail: david.kinsgmore@ggc.scot.nhs.uk

Back to Top | Article Outline
NCT01706354

Local Anesthesia vs Regional Block for Arteriovenous Fistulae

Ages eligible for study: 18 years and older

Sponsors and collaborators: Emma Aitken, NHS Greater Glasgow and Clyde

Contact: Marc Clancy, MBBS, PhD

Phone: 0141 211 1750

E-mail: Marc.Clancy@ggc.scot.nhs.uk

Contact: Emma Aitken, MBChB, MRCS

Phone: 0141 211 1750

E-mail: Emma.Aitken@nhs.net

Back to Top | Article Outline
NCT01704313

A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic Fistulae

Ages eligible for study: 18 years and older

Sponsors and collaborators: Emma Aitken, NHS Greater Glasgow and Clyde

Contact: Emma L. Aitken, MBChB

Phone: 01412111750

E-mail: EmmaAitken@nhs.net

Contact: David B. Kingsmore, MBChB

Phone: 01412111750

E-mail: david.kingsmore@ggc.scot.nhs.uk

Back to Top | Article Outline

• Hypertension •

NCT01737138

Renal Sympathetic Denervation in Patients with Chronic Kidney Disease and Resistant Hypertension Ages eligible for study: 18 years to 75 years

Sponsors and collaborators: The First Hospital of Nanjing Medical University

Contact: Shan Qi Jun

Phone: 0086 025 68136407

E-mail: qjshan@njmu.edu.cn

Back to Top | Article Outline
NCT01713270

Renal Sympathetic Denervation in Patients with Hypertension and Symptomatic Atrial Fibrillation

Ages eligible for study: 18 years to 75 years

Sponsors and collaborators: The First Hospital of Nanjing Medical University

Contact: Qijun Shan

Phone: 0086 025 68136407

E-mail: qjshan@njmu.edu.cn

Back to Top | Article Outline
NCT01703780

The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis

Ages eligible for study: 30 years to 75 years

Sponsors and collaborators: Cardiovascular Institute & Fuwai Hospital, Huazhong University of Science & Technology, Shanghai Jiao Tong University School of Medicine

Contact: Rutai Hui

Phone: 86-010-88398154

E-mail: huirutai@gmail.com

Back to Top | Article Outline
NCT01712620

Spironolactone for Pulmonary Arterial Hypertension

Ages eligible for study: 18 years and older

Sponsors and collaborators: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Pennsylvania; University of Maryland Medical Center; Washington Hospital Center

Contact: Grace M. Graninger, RN

Phone: 301-496-9320

E-mail: ggraninger@cc.nih.gov

Contact: Michael A. Solomon, MD

Phone: 301-496-9320

E-mail: msolomon@cc.nih.gov

Back to Top | Article Outline
NCT01702688

Evaluation of Lysine-Specific Demethylase 1

Ages eligible for study: 18 years to 65 years

Sponsors and collaborators: Brigham and Women's Hospital

Contact: Bindu Chamarthi, MD

Phone: 617-732-5666

E-mail: bchamarthi@partners.org

Back to Top | Article Outline

• Sepsis •

NCT01682590

I.D.E.A.L.-I.C.U. (Initiation of Dialysis EArly Versus Late in Intensive Care Unit)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Centre Hospitalier Universitaire Dijon

Contact: Jean-Pierre Quenot

Phone: 3 80 29 36 85, ext. 33

E-mail: jean-pierre.quenot@chu-dijon.fr

Back to Top | Article Outline

• Miscellaneous •

NCT01671228

Developing and Evaluating the Yorkshire Dialysis Decision Aid

Ages eligible for study: 18 years and older

Sponsors and collaborators: University of Leeds, Kidney Research UK, National Health Service, Baxter Healthcare Corporation, Foundation for Informed Medical Decision Making, X-Lab Systems

Contact: Hilary L. Bekker, PhD

Phone: 0113-343-2726

E-mail: h.l.bekker@leeds.ac.uk

Contact: Martin Wilkie, MD

Phone: 0114-271-5327

E-mail: martin.wilkie@sth.nhs.uk

Back to Top | Article Outline
NCT01685658

Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations

Ages eligible for study: 18 years and older

Sponsors and collaborators: Centre Hospitalier Universitaire de Nīmes

Contact: Pierre-Géraud Claret, MD

Phone: +33 (0) 4 66 68 80 83

E-mail: pierre.geraud.claret@gmail.com

Contact: Carey Suehs, PhD

Phone: +33 (0) 4 66 68 67 88

E-mail: carey.suehs@chu-nimes.fr

Back to Top | Article Outline
NCT01690039

Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis

Ages eligible for study: 18 years and older

Sponsors and collaborators: Bern University Hospital

Contact: Daniel Fuster

Phone: +41 (0) 31 631 37 49

E-mail: daniel.fuster@ibmm.unibe.ch

Contact: Nasser Dhayat

Phone: +41 (0) 31 632 31 44

E-mail: nasser.dhayat@insel.ch

Back to Top | Article Outline
NCT01711853

Study in Severe Renal Patients to Investigate Dabigatran Etexilate

Ages eligible for study: 18 years to 80 years

Sponsors and collaborators: Boehringer Ingelheim Pharmaceuticals

Contact: Boehringer Ingelheim Call Center

Phone: 800-243-0127

E-mail: clintriage.rdg@boehringer-ingelheim.com

Back to Top | Article Outline
NCT01705132

Urinary Biomarkers of the Progression of Alport Kidney Disease

Ages eligible for study: 5 years to 65 years

Sponsors and collaborators: University of Minnesota Clinical and Translational Science Institute, Novartis

Contact: Theresa Cassidy, MPH, CCRP

Phone: 612-626-7632

E-mail: cassi044@umn.edu •

© 2012 Lippincott Williams & Wilkins, Inc.

Login